focus -WSS

focus

author：hotspot 2025-09-06 03:28:23 - browse：818

Is no one safe from the FTC? Has Pfizer bottomed out? And is biotech finally back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we delve into the fallout over the FTC’s move to block what looked like a humdrum biotech deal between Sanofi and Maze Therapeutics, a surprising twist that leaves an unanswered question. We also discuss the latest news in the life sciences, including Pfizer’s downbeat future, Vertex Pharmaceuticals’ next big thing, and a newly minted biotech VC with a very famous name.

For more on what we cover, here’s the FTC news; here’s more from Maze Therapeutics; here’s the Pfizer news; here’s the latest on Vertex; here’s the story behind its pain drug; here’s the Reed Jobs profile; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： No plane should take off without an EpiPen onboard

Wikipedia

WSS

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

What the US credit downgrade means for the economy, your finances

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Pence says 'crackpot lawyers' told Trump what he wanted to hear

Use doctors trained outside the U.S. to ease the physician shortage

entertainment

focus

hotspot

How one medical school became remarkably diverse

What affirmative action's end means to a medical student

Jerome Adams on the need for new antivirals for Covid

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Medical leaders decry Supreme Court decision on affirmative action

Wildfire pollution widens asthma inequities on Long Island

Cancer drug shortages should be causing more outrage

Use doctors trained outside the U.S. to ease the physician shortage

The high cost of giving birth even with insurance

Mega Millions pot grows to $1.25 billion after no winner

hotspot

Physician groups backed by private equity giant lobby on mergers

Physician groups backed by private equity giant lobby on mergers

The high personal cost of affirmative action for Black doctors

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

STAT wants to know your pick for a great summer read or listen

leisure time

hotspot

Wikipedia

focus